ABSTRACT In a previous study, we reported on a quantitative transcriptomic method which confirmed the temporal transcription of developmental fast skeletal muscle myosin heavy chain (fsMyHC) embryonic isoforms in the embryonic Pectoralis major (PM) of the Single Comb White Leghorn (SCWL). The objective of the current study was to further investigate the transcriptional events underlying embryonic PM growth in the SCWL and a genotype exhibiting partial muscular dystrophy, the Low Score Normal (LSN). We hypothesized that within the SCWL and LSN embryos, there would be differences in the temporal transcription of the fsMyHC isoforms and other myogenic regulatory genes. Samples of PM tissues were collected daily from embryonic day (ED) 6 through ED19. Total RNA was isolated from each PM tissue sample and mRNA transcripts from 28 target genes were simultaneously quantified using a probe hybridization method. Raw data counts were normalized against the geometric mean of 5 housekeeping genes and analyzed using Local Regression (LOESS) smoothing methods. Predicted estimates based on LOESS smoothing were plotted with 95% upper and lower confidence intervals, allowing for line comparisons between the SCWL and LSN. Differences (P < 0.05) were determined by nonoverlapping confidence intervals between the SCWL and LSN. Among genes exhibiting line differences (P < 0.05), were the developmental fsMyHC isoforms, transcription factors, growth factors, and proteoglycans. The current study is the first to report transcription of the chicken fast skeletal adult myosin isoform (Cad) during PM myogenesis. Samples were submitted for capillary-liquid chromatography-tandem mass spectrometry analysis which confirmed the translation of all the developmental fsMyHC isoforms including Cad in both lines. The LSN exhibited altered transcription patterns of early myogenic markers (MYOD, MRF4, Cemb1, six4, and pax3) during late embryogenesis, continued transcription of Cvent, and delayed transcription of Cneo.
INTRODUCTION
The Pectoralis major (PM) is the predominant breast muscle in avian species and is a major economic driver for the broiler industry (National Chicken Council, 2012 ). As such, factors which influence breast muscle growth are a primary focus for commercial breeders and muscle biologists (Havenstein et al., 1994; . In poultry, the number of muscle fibers is largely fixed at the time of hatching (Glass, 2005) . Post-hatch muscle growth is largely via hypertrophy and can be influenced by cellular regulatory events occurring during embryonic myogenesis when the proliferation (hyperplasia) of future muscle cells is greatest.
Embryonic myogenesis is a complex but precisely regulated developmental process that includes cellular C 2017 Poultry Science Association Inc. Received July 6, 2016. Accepted November 16, 2016. 1 Corresponding author: wick.13@osu.edu migration and a balance between the proliferation of pre-myogenic cells followed by differentiation later in the myogenic cycle. As myoblasts undergo proliferation, they migrate and fuse into multinucleated myotubes that subsequently differentiate into mature muscle fibers (Ben-Yair and Kalcheim, 2005) .
The six homeobox transcription factors (TFs), six1 and six4, direct dermomyotomal progenitors toward the myogenic lineage through binding and translocating eyes-absent homologs eya1 and eya2 to the nucleus, thereby activating the target regulatory genes, MYOD, MRF4, myogenin, and pax3 (Buckingham 2001; Grifone et al., 2005; Niro et al., 2010) . Skeletal muscle progenitor cells that are positive for the pairedbox (pax) transcription factor, pax3, are destined for muscle cell delineation (Williams and Ordahl, 1994) and these cells activate a cadre of myogenic regulatory genes before differentiating into skeletal muscle fibers (Maroto et al., 1997; Tajbakhsh et al., 1997) . The second paired-box TF, pax7, is a lineage marker expressed by quiescent and activated myogenic satellite cells dur-1531 ing both muscle growth and muscle regeneration (Seale et al., 2000) .
During avian myogenesis, the earliest reported regulatory factors associated with the onset of myogenic determination is the MYOD family (MDF) of basic helix-loop-helix (bHLH) TFs (MYOD, myogenin, myf5, MRF4; Pownall and Emerson, 1992; Rudnicki et al., 1993) . The MDF TFs facilitate proliferation, control differentiation and are among the first markers of early myogenesis (Molkentin and Olson, 1996; Rawls and Olson, 1997) .
Myogenin, a member of the bHLH family of growth factors, activates the transcription of myosin heavy chain (Ludolph and Konieczny, 1995; Arnold and Braun, 1996) . Myosin, a fibrous contractile protein, is critical for contraction of all muscle including the fast skeletal muscle present in the PM. Myosin represents approximately 70% of the total protein found within the thick filament of individual sarcomeres and 40 to 50% of total muscle protein (Wick, 1999) . During the course of embryonic and post-hatch growth, fast skeletal muscle heavy chain myosin (fsMyHC) is sequentially expressed as six developmental isoforms (Bandman, 1985; Crow and Stockdale, 1986; Cerny and Bandman, 1987; Stockdale and Miller, 1987; Bandman and Bennett, 1988; Tidyman et al., 1997) . The isoforms are temporally expressed and their pattern of expression is influenced by both genetic (Wick et al., 2003; Reddish et al., 2005; Lee et al., 2012) and environmental factors (Huffman et al., 2012) . During the course of embryogenesis in the PM, there is sequential expression of six isoforms although three embryonic myosin isoforms predominate (Cemb1; Cemb2, Cemb3; Tidyman et al., 1997; Griffin et al., 2016) . The molecular mechanisms underlying differential transcription during embryogenesis associated with post hatch muscle characteristics in the PM remains largely unresolved.
One objective of the current study was to expand the scope of the embryonic myosin data generated by Griffin et al. (2016) to elucidate the transcriptional events associated with differential myogenesis between a control and intermediate myopathic strain of chickens. The embryonic samples in the current study included both the Single Comb White Leghorn (SCWL) (Griffin et al., 2016) and those from a partially dystrophic line, the Low Score Normal (LSN). Muscular dystrophy in chickens is not a new observation, it was initially reported by Asmundson et al. (1956) in chickens derived from a commercial source of New Hampshire (NH) strain broilers. These birds were the original source of what was to become the University of California-Davis 301 dystrophic line (Wilson et al., 1979) . Dystrophic sublines of the Davis 301 NH line were subsequently selected for early or late onset of the anomaly and high or low lipid content in the breast muscle (Holliday et al., 1968; Ashmore and Doerr, 1971) . Hens from the Davis 301 NH line were subsequently crossed and backcrossed with SCWL males (Chung et al., 1960) and this became the base for the dystrophic SCWL line that was later established at the University of Connecticut (UConn) (Wilson et al., 1979) .
One of the first clinical symptoms of the homozygous dystrophic phenotype is the inability of individual birds to right themselves when placed on their back and this was subsequently referred to as a "flip test" or "exhaustion score" (Julian, 1973; Wilson et al., 1979) . The LSN line used in the current experiment was originally an outcross of the UConn dystrophic line with a commercial SCWL line resulting in reduced PM muscle mass compared to the SCWL (Velleman et al., 1996) . The LSN could be differentiated from homozygous dystrophic and control SCWL chicks through differences in exhaustion scores with SCWL, LSN, and homozygous dystrophic chicks having exhaustion scores of approximately 28/30 to30/30, 9/30 to 12/30, and 0 to 3/30, respectively (Velleman and Coy, 1997; . Kikuchi et al. (1981) had also used differences in exhaustion scores to distinguish between homozygous dystrophic and heterozygous chicks derived from the UC Davis dystrophic lines.
The LSN has subsequently been used as a comparative model for studies looking at late embryonic and post-hatch changes in muscle morphology and interrelationships between the extracellular matrix and muscle development (Velleman et al., 1995; Velleman and Coy, 1997; . The extracellular matrix, in particular syndecan-4, glypican-1, and decorin have been the most extensively described proteoglycans with respect to muscle changes in LSN chicks. The former two, syndecan-4 and glypican-1 are cell membraneassociated heparan sulfate proteoglycans (HSPGs) that modulate the activity of muscle growth factors and activate signal transduction pathways. The syndecan family of proteoglycans are transmembrane proteoglycans with primarily heparan sulfate bound to their extracellular domain although syndecans-1 and -4 may contain chondroitin sulfate as well (Carey, 1997; Elfenbein and Simons, 2013) . Rapreager et al. (1991) reported that myoblast differentiation stimulated by bFGF (FGF-2) had a requirement for heparan sulfate extracellular binding. Syndecan-4 was subsequently shown to bind both the growth factor and its receptor and thus serve as a co-receptor and through this mechanism modulate the response to FGF-2 (Rapraeger, 2000) . While it is well recognized that syndecan-4 regulates FGF-2 mediated responses in muscle, there is evidence of a similar relationship between syndecan-4 and FGF-1 in other systems (Iwabuchi and Goetinck, 2006) .
Glypican is another heparan sulfate proteoglycan that is membrane associated via a phospholipid anchor and also has the ability to bind FGF2 (Steinfeld et al., 1996; Brandan and Larrain, 1998) . Skeletal muscle differentiation is inhibited by FGF (Dollenmeier et al., 1981) and glypican-1, which is present throughout the myogenic process, purportedly blocks differentiation by sequestering FGF2 and thus blocking receptor binding (Gutierrez and Brandon, 2010) .
Decorin is a non-membrane associated extracellular matrix proteoglycan that belongs to a family of small, leucine rich proteoglycans β (Iozzo, 1999) . It contains chondroitin/dermatan sulfate and can activate and/or sequester transforming growth factor (TGF-β) similar to what is observed between the syndecans/glypican and FGF. The difference is that decorin exerts if effect via binding with its core protein (Hildebrand et al., 1994; Takeuchi et al., 1994) . There are independent, core protein binding sites for both Type I collagen and TGF-β and this is one mechanism proposed for developing collagen fibril stability (Riquelme et al., 2001) . With respect to the current study, there are reports linking decorin with collagen expression and morphological differences between the LSN and SCWL pectoral muscle samples (Velleman et al., 1996; Velleman and Coy, 1997; Velleman and McFarland, 1999) as well as genotype differences related to the regulatory effects of TGF-β on decorin expression (Velleman and Coy, 1998; Li et al., 2008) . Insulin-like growth factor-1 (IGF-1) mediates signal transduction through binding to its receptor (IGF-1R) which activates intracellular pathways leading to an increase in myoblast proliferation and differentiation (Barton et al., 2002; Glass, 2005, Bassel-Duby and Olson) . A deficiency in IGF-1 has been reported to result in a severe form of muscular dystrophy in mice (Powell-Braxton et al., 1993) .
The morphological and biochemical differences between the SCWL and LSN make it a useful comparative model. In the current study, we investigated the differences in temporal transcription of the fsMyHC isoforms and other myogenic regulatory genes throughout embryogenesis using the novel transcription technique described by Griffin et al. (2016) . There have been no previous reports on changes in the transcription of multiple myogenic regulatory factors over the course of embryonic development, let alone a comparison of genotypes with documented differences in muscle morphology.
MATERIALS AND METHODS

Pectoralis Major (PM) Tissue Extraction
Control SCWL and LSN embryos used in this study were from lines maintained at the Ohio Agricultural Research and Developmental Center at The Ohio State University. Eggs were incubated at an industry standard of 37.5
• C and embryos were removed from the incubator on chronological days 6 through day 19. All embryos were sacrificed by decapitation, at which point the PM breast muscle was exposed and removed from each side of the sternum. The left PM breast muscle was flash frozen in liquid nitrogen and stored at −80
• C for gene transcriptional analysis. The Right PM breast muscle was homogenized in urea thiourea (UTU) storage buffer and stored at −20
• C for proteomic analysis. Total RNA was extracted using a Norgen Animal Tissue Specific Isolation kit according to the manufacturer's protocol (Norgen Biotek Corp, Thorold Ontario, Canada). Total RNA concentration and integrity were evaluated using a NanoDrop Spectrophotometer (Thermo Scientific), gel electrophoresis, and Agilent 2100 bioanalyzer (Agilent Technologies, Santa Clara, CA). It should be noted that RNA Integrity Number (RIN) score is not an appropriate quality control measurement, as the nCounter technology is well suited for degraded samples. The only RNA quality measurement required is that at least 50% of the RNA is greater than 500 nucleotides in length.
NanoString nCounter Transcript Abundance Analysis.
We previously reported the use of NanoString nCounter system for gene transcript quantification during PM embryonic growth in the SCWL (Griffin et al., 2016) . The same methodology was utilized in the current study, with the addition of LSN embryonic samples for comparative analysis in gene transcription. Digital counts for all target genes (Table 1) were simultaneously quantified using total RNA extracted from each PM sample (1 embryo/day/line). All digital counts were adjusted for binding efficiency with background subtraction using positive and negative controls supplied by the manufacturer (Nanostring Technologies, Seattle, WA), as per Nanostring nCounter data analysis guidelines.
Probe Architecture The nCounter analysis system uses unique color-coded molecular barcodes that hybridize directly to nucleic acids through the use of gene specific color-coded probe pairs. In solution, the probes capture and count specific nucleic acid molecules in a complex mixture by hybridizing directly to the target mRNA for digital detection. The digital color-coded barcodes consist of unique combinations of 4 spectrally non-overlapping dyes arranged at 7 contiguous regions, making it possible to generate hundreds of unique transcripts, each corresponding to 1 target gene, in a single reaction. Each target gene of interest is detected using a pair of reporter and capture probes carrying 35-to 50-base target-specific sequences. Each reporter probe is the "barcode", carrying a unique color code assigned to each target mRNA sequence at the 5 end that enables the molecular barcoding for detection of the target mRNA in solution. This technology has been shown to achieve superior gene expression quantification results when compared to RT-Polymerase Chain Reaction (Reis et al., 2011) .
Statistical Analyses
All data were analyzed according to (Griffin et al., 2016) using nSolver software provided by NanoString. Housekeeping gene normalization was performed in order to adjust the digital counts of all probes that were not expected to vary between samples. A normalization factor was calculated based on the average of CCAAAGAAGAAGATTCACCGCAGAGTCCTGAAAAAGAACCCGCTGAAGAATCTGAGAGTCATGATAAAGCTGAACCCATACGCCAAAACAATGCGACGCA the geometric mean of all 5 housekeeping genes for each data point. The average of the geometric means across all data points was used as a reference against which each lane was normalized. Following normalization, gene transcription measurements were regressed on days of incubation using the LOESS (i.e., local regression) procedure of SAS V9.2, a non-parametric regression method that combines multiple regression models in a k-nearest neighborhood model (Cleveland and Devlin, 1988) . LOESS regressions allow great flexibility in estimating response curves because they make no assumptions about the parametric form of the regression. The optimal smoothing parameter was determined using cross-validation. As with conventional regression methods (e.g., least-squares), LOESS produces prediction estimates as well as standard errors of these estimates.
For all data presented as quantitative transcription counts, LOESS prediction values were graphed with 95% confidence represented by 5% upper and lower confidence intervals. For relative transcription data, comparisons of genetic lines on given days were done using t-tests based on the predictions and standard errors of each line. Rates of change in gene transcription were calculated using finite forward and backward differences (half-days). For all data, significance was declared at P < 0.05, indicated by non-overlapping 5% upper and lower confidence intervals and 5% error bars.
Proteomic Validation of fsMyHC isoforms
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) PM tissue samples were homogenized in 1 mL sample buffer (8 M urea, 2 M thiourea, 20 mM dithiothreitol, 50 mM tris, 3% SDS, 0.004% bromophenol blue, pH 6.8) and whole muscle proteins were resolved according to Zapata et al. (2011) . Gels were stained with Coomassie Brilliant Blue G250 and subsequently destained with 10% acetic acid according to Huffman et al. (2012) . Samples were normalized to give relatively similar protein band size at the expected fsMyHC molecular weight of 230 kDa (Figure 1) .
Mass Spectrometry The individual fsMyHC protein bands were excised from the SDS-PAGE gel, subjected to protease digestion, and analyzed by capillary-liquid chromatography-tandem mass spectrometry (LC-MS/MS). The resulting files were searched against all National Center for Biotechnology Information (NCBI) entries for Galllus gallus (database prepared on 30 April 2009, 10,973 entries) using MASCOT, from which only confident identifications (P < 0.05) were accepted. Protein identifications were checked manually and proteins with a Mascot score of 50 or higher with a minimum of two unique peptides from one protein were accepted. 
RESULTS AND DISCUSSION
Body weight (BW), PM, and P. minor weights were obtained from similar aged adult SCWL and LSN birds (n = 10) to confirm muscle weight differences posthatch between the two lines. The mean BW, PM, and P. minor weights were compared using Student t test and were significantly different (P < 0.05; Table 2 ). Compared to the SCWL, LSN adult birds had a 21% reduction in BW, 53% reduction in PM muscle mass and a 56% reduction in P. minor muscle mass. These data corroborate that reported by Velleman et al. (1996) , who showed a decrease in both BW and PM muscle mass in the LSN compared to the SCWL.
Target genes were selected based on their known roles in skeletal myogenesis (refer to Introduction). The quantitative gene transcription data are displayed as smoothed curves with 95% upper and lower confidence limits for each genetic line. Both curves (SCWL and LSN) were plotted together, where (P < 0.05) line differences in gene transcription are indicated by regions of non-overlapping 95% upper and lower confidence intervals.
MyoD Family (MDF) of basic Helix-Loop-Helix TFs
Line differences (P < 0.05) in MYOD ( Figure 2A ) and MRF4 ( Figure 2B ) transcription are present during mid-late embryogenesis. In the SCWL, MYOD, and MRF4 transcription peaked on embryonic day (ED)12 and ED14, respectively, and were subsequently downregulated throughout the remainder of embryogenesis. In contrast, MYOD and MRF4 transcription in the LSN did not peak, but rather continued to increase relative to the SCWL throughout the course of embryonic growth.
MYOD is required for the initial commitment to the myogenic lineage, while MRF4 is required during myoblast differentiation (Buckingham, 2001 ). Thus, their predominant transcription during early embryogenesis, with peak transcription of MYOD (ED12) occurring before MRF4 (ED14), in the SCWL, is expected. Alternatively, the continual increase in MYOD transcription observed in the LSN suggests that the LSN is still in the process of recruiting progenitor cells to the myogenic lineage. In addition, the continued increase in MRF4 transcription could indicate that the previously committed myogenic cells are differentiating which contributes to the decrease in muscle mass observed post-hatch in the LSN. There were no line differences observed in the remaining two bHLH transcription factors, myogenin ( Figure 2C ), and Myf5 ( Figure 2D ).
SIX Homeobox TFs (Six1 and Six4)
Line differences (P < 0.05) in six4 transcription started on ED15 ( Figure 3A) . At this age, transcription peaked in the SCWL and subsequently declined throughout the remainder of embryogenesis. In contrast, six4 transcription in the LSN continually increased without the downregulation observed in the SCWL. The decline observed in the SCWL during late embryogenesis is expected as six4 is known to direct dermomyotomal progenitors toward the myogenic lineage which takes place during early embryonic growth (Buckingham 2001; Grifone et al., 2005) . There was no difference in six1 transcription between the SCWL and LSN as indicated by overlapping 95% confidence intervals ( Figure 3B ).
Paired Box (PAX) TFs (Pax3 and Pax7).
In the current study, pax3 transcription in the SCWL was highest on ED5 followed by a sharp decline approaching zero by ED18 ( Figure 4A) . A similar transcription pattern is displayed in the LSN until ED14 at which point there was a spike in transcription that occurred in the LSN (P < 0.05) which continued through the remainder of embryogenesis. The predominant transcription of pax3 during early embryogenesis seen in the SCWL is expected, as pax3 is required for the initial commitment of muscle progenitor cells to the myogenic lineage, and activation of MDFs. during early embryonic development (Williams and Ordahl, 1994; Buckingham et al., 2003) . There was no difference in pax7 transcription between the SCWL and LSN as indicated by overlapping 95% confidence intervals ( Figure 4B ).
The continual increase in both six4 and pax3 transcription during late embryogenesis, in the LSN, is unexpected as commitment of muscle progenitor cells to the myogenic program should have already occurred, as indicated by the activation of MDFs (Figure 2 ). The degradation of pax3 via the ubiquitin/proteasome system (UPS) is essential for the onset of differentiation, as delayed myotube fusion and decreased expression of fsMyHCs and myogenin, have been reported with increasing pax3 stability (i.e., inhibiting degradation) (Boutet et al., 2007) . Sustained pax3 and six4 transcription during late embryogenesis suggests continued recruitment of muscle progenitor cells towards the myogenic lineage in the LSN with a concomitant reduction in the progression from proliferation to differentiation.
Fast Skeletal Muscle Myosin Heavy Chain (fsMyHC) Embryonic Isoforms
The temporal transcription of fsMyHC isoforms was previously reported in the SCWL as a percentage of total myosin (Tidyman et al., 1997; Griffin et al., 2016) . For comparative purposes, Figure 5 displays the temporal transcription of the different fsMyHC isoforms as a percentage of total myosin in the LSN (top) compared to that previously reported by Griffin et al. (2016) in the SCWL (bottom). A transition period as defined by a shift from Cemb1 and Cemb2 to Cneo transcription can be observed at approximately ED13-15. Figure 5 also shows a delay in Cneo transcription in the LSN (∼ED14) as compared to the SCWL (∼ED10) (P < 0.05). This further supports the previously stated hypothesis that the LSN is struggling to transition to a more differentiated stage of development.
Line comparisons for the quantitative transcription of fsMyHC isoforms are shown in Figure 6 . Line differences (P < 0.05) in Cvent transcription are present on ED5 and ED6 ( Figure 6A ) as shown by an increase in transcription in the LSN compared to the SCWL. There data are consistent with the reported delay in Cvent expression in the LSN compared to the SCWL (Wick et al., 2003) . Cvent transcription in the SCWL has previously been reported to start declining at this stage (Tidyman et al., 1997) . This is further evidence that the LSN is struggling to fully transition from proliferation to an early differentiated stage of development. The temporal transcription of fsMyHC isoforms shifts from Cvent to the embryonic isoforms, starting with Cemb1 ( Figure 5 ). Line differences (P < 0.05) in Cemb1 transcription initiated on ED10 and peak transcription occurred earlier in the SCWL (ED14) compared to the LSN (ED19) ( Figure 6B ). This further supports a hypothesis that the LSN is struggling to fully transition to a more differentiated or mature stage of development. Line differences (P < 0.05) in Cemb2 transcription initiated on ED13 and in contrast to what was observed for Cemb1, peak transcription of Cemb2 occurred earlier in the LSN (ED15) compared the SCWL (ED18), with an increase in transcription levels occurring in the SCWL ( Figure 6C ). There were no differences in the transcription patterns of the final embryonic fsMyHC isoform, Cemb3, between the SCWL and LSN as indicated by overlapping 95% confidence intervals ( Figure 6D ).
The data presented in Figure 6E show there is a delay in Cneo transcription in the LSN as indicated by decreased transcription levels compared to the SCWL (P < 0.05). The delays in Cvent and Cneo transcription in the current study are additional data supporting delayed embryonic myogenic programming associated with the LSN phenotype. Tidyman et al. (1997) , using a sensitive quantitative northern blot technique, failed to report any presence of the adult isoform (Cad) in the PM of embryonic SCWL but did observe Cad transcription in the SCWL at 10 days' post-hatch (Tidyman et al., 1997) . The current study is the first to report the transcription of the Cad isoform during embryonic development in avian species ( Figure 6F ) using the molecular technique described by Griffin et al. (2016) which greatly improves the quantification of gene transcription compared with RT-PCR (Reis et al., 2011) . Initial transcription occurred at approximately ED10 and continued to increase throughout embryogenesis in both the SCWL and LSN. Although no line differences were observed for Cad, it should be noted that peak transcription occurred earlier in the LSN (ED17) compared to SCWL (ED19) ( Figure 6F ).
Transcription patterns of the remaining developmental fsMyHC isoforms (Cemb1, 2, 3, and Cneo) are consistent with the current literature. Thus, it is likely that the reported Cad transcription, initiating on ED10, is a reflection of the sensitivity of the method used. To address the apparent discrepancy between previous literature reports and the data reported herein, LC-MS/MS was performed to confirm the translation of all developmental fsMyHC isoforms to their corresponding protein ID within the NCBI database (Table 3) . Proteomic results confirmed the translation of all fsMyHC isoforms with the exception of Cneo and confirmed our transcription data relative to the ED10 expression of Cad. Expression of Cneo could not be confirmed because the target mRNA sequence specific to the Cneo isoform is located within the 3 untranslated region (3 UTR). 
Proteoglycans and Growth Factors
In the current study, two cell membrane-associated heparan sulfate proteoglycans (HSPGs); syndecan-4 and glypican-1 and the small leucine rich proteoglycan, decorin were differentially transcribed in the SCWL and LSN. Syndecan-4 is expressed at high levels in embryonic myoblasts (Cornelison et al., 2001) , and has been shown to play a key role in cell migration (Shin et al., 2013) and the expression of myogenic transcriptional regulatory factors (Shin et al., 2012 ). In the current study, syndecan-4 transcription increased throughout embryogenesis in both the SCWL and LSN ( Figure 7A ). Line differences (P < 0.05) were present throughout embryogenesis, with an increase in syndecan-4 transcription levels in the LSN compared to the SCWL.
As previously mentioned, there is evidence that syndecan-4 may interact with FGF-1 (Iwabuchi and Goetinck, 2006) in a relationship similar to that of FGF-2; by binding both the growth factor and its cellular receptor, acting as a co-receptor (Rapraeger, 2000) . In the current study FGF-1 transcription continually increased throughout embryogenesis in the SCWL and LSN ( Figure 7B ). Line differences (P < 0.05) initiated on ED14, at which point transcription in the LSN increased throughout the remainder of embryogenesis compared to the SCWL. The increased demand for syndecan-4, required during cell migration, in the LSN compared to the SCWL, as shown by increased transcription levels, provide further support for the continued recruitment of progenitor cells to the myogenic lineage and lack of necessary transitions through the stages of differentiation resulting in sustained proliferation of myoblasts.
The second HSPG, glypican-1, is a known marker for myotube differentiation (Brandan et al., 1996; Li et al., 2006 ). In the current study, glypican-1 transcription peaked during mid embryogenesis in both SCWL and LSN, with line differences (P < 0.05) occurring during mid and late embryogenesis ( Figure 7C ). Glypican-1 transcription in the LSN was increased from ED9-ED15 compared to the SCWL (P < 0.05) after which time transcription declined to nearly zero. However, peak transcription occurred later in the LSN (ED14) followed by a dramatic decline whereas in the SCWL, there was an earlier peak in transcription (ED13) followed by a plateau ( Figure 7C ).
The increased demand for glypican-1 during mid embryogenesis in the LSN, is further support for the hypothesis that in the LSN there is a period of prolonged myoblast proliferation thereby requiring an increase in glypican-1 transcription during early stages of differentiation. Furthermore, the later peak in glypican-1 transcription, in the LSN, support the inadequate transition through differentiation stages.
Decorin, a small leucine-rich proteoglycan is a component of the extracellular matrix (ECM), previously identified in skeletal muscle of poultry (Velleman et al., 1996; 1997) . The interaction of myoblasts with the ECM is required for cell fusion aiding in the formation of multinucleated myotubes (Velleman, 1999) . Using in vitro methods, Li et al. (2006) , reported accelerated differentiation, increased number and size of myotubes, and an elevated expression of muscle specific genes; myf6, MYOD, myogenin, and MyHC, in decorin treated myoblasts. In addition, elevated expression of decorin, followed by a subsequent increase in collagen cross-linking has been reported during late PM embryonic development (ED20) in the LSN compared to the control SCWL line at the same ED (Velleman et al., 1996; Velleman and Coy 1997) .
In the current study, decorin transcription increased throughout embryogenesis in the SCWL ( Figure 7D) . A similar transcription pattern was documented in the LSN until ED16, at which point line differences (P < 0.05) initiated, with a drop in transcription in the LSN. The SCWL data are consistent with the current literature, in that, an upregulation of decorin is expected during late embryogenesis when differentiation and fusion of myoblasts is occurring. The LSN data contradict previous reports showing an increase in decorin expression on ED20 compared to the SCWL (Velleman et al., 1996) . This discrepancy can likely be attributed to different methods used, in conjunction with the inherent variability in physiological stage of embryos of the same chronological age. This emphasizes the importance of one goal of this study which was to characterize the transcription patterns of numerous muscle regulatory factors over the continuum of embryonic development to provide a comprehensive view of the relationships underlying transcriptional events influencing embryonic PM growth.
As previously mentioned, decorin has been shown to have modulatory effects on TGF-β2 activity (Hildebrand et al., 1994; Takeuchi et al., 1994) and no line differences were observed in TGF-β2 transcription ( Figure 7E ). In addition to its functional role in cell migration and myoblast-ECM interactions, decorin has also been shown to bind insulin-like growth factor-1 (IGF-1; Schonherr et al., 2005) . IGF-1 mediates signal transduction cascades leading to an increase in both myoblast proliferation and differentiation (Barton et al., 2002; Glass, 2005; Bassel-Duby and Olson, 2006 ). In the current study, decorin and IGF-1 exhibit similar transcription patterns unique to each line ( Figure 7F ). Similar to decorin, IGF-1 transcription increased throughout embryogenesis in the SCWL. Line differences (P < 0.05) were initially observed at ED9 and the LSN displayed markedly inconsistent transcription thereafter.
CONCLUSION
The present study provides a comprehensive overview of the transcriptional events underlying embryonic PM growth in two unique poultry lines. We hypothesized that within the SCWL and LSN embryos, there would be differences in the temporal transcription of the fsMyHC isoforms and other myogenic regulatory genes. Our results demonstrate significant line differences, between the SCWL and LSN, in the temporal transcription of multiple regulatory genes involved in skeletal myogenesis. In the SCWL, the temporal transcription of target genes throughout embryogenesis were consistent with the current literature in that previously described genes involved in regulatory mechanisms during early, mid, or late embryogenesis, were predominantly transcribed during that stage of development in the SCWL.
A few key observations were made from the altered transcription patterns observed in the LSN, when compared to the SCWL. This includes the sustained transcription of early myogenic markers (MYOD, MRF4, Cemb1, six4, and pax3) during late embryogenesis in the LSN. In addition, altered temporal transitions for the developmental fsMyHC isoforms occurred in the LSN compared to the SCWL. There was increased Cvent transcription on ED5 and ED6 in the LSN when transcription was downregulated in the SCWL and also a delay in Cneo transcription in the LSN. Lastly, the majority of differentially transcribed genes in the LSN and SCWL play a pivotal role in the progression from a proliferative to differentiation state.
In addition to reporting line differences between the SCWL and LSN, we observed potential relationships among differentially transcribed genes as defined by two genes which exhibited analogous transcription patterns throughout embryogenesis that was unique to each line. For example, two potential associations between the Cemb1 fsMyHC isoform and the myogenic regulatory gene MRF4 and Cemb2 and glypican-1. As previously mentioned, MRF4 and glypican-1 are both necessary for myoblast differentiation. The data suggest that there may be multiple stages of differentiation and the fsMyHC isoforms may be associated with these stages.
Collectively, this study suggests that there are differences in myogenic programing occurring in the LSN. There is ample evidence presented suggesting that the LSN lacks the signals required for the downregulation of early myogenic gene transcription, thus preventing or delaying the normal progression or transition through the proliferation and differentiation stages of myogenesis. This possibly leads to a failure of LSN muscle cells to achieve an optimal residence time within different stages of differentiation, leading to differences in relative rates of proliferation and differentiation compared to the SCWL, leading to the reduced muscle mass inherent to the LSN PM. Furthermore, it possible that the differential transcription of genes critical for the successful progression through the myogenic program likely have a direct influence on the integrity and number of muscle fibers formed at birth and therefore potential for post-hatch hypertrophic growth. The results from the current study provide a platform for future investigation aimed at targeting specific mechanisms driving the differences in the LSN and alternatively, mechanisms responsible for myogenesis.
